SCHEMBL15324655

SCHEMBL15324655

CCNc1c(N)cc(C(=O)OC)c2c1OCCO2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.50
ALDH1A1 P00352 5/20 0.50
HSD17B10 Q99714 4/20 0.38
GAA P10253 3/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
GLA P06280 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
ATM Q13315 1/20 0.37
CFTR P13569 1/20 0.36
ABL1 P00519 1/20 0.36
HTR4 Q13639 11/20 0.36
HTR2C P28335 3/20 0.36
ADRA2B P18089 2/20 0.36
ADRA2C P18825 2/20 0.36
HTR1D P28221 2/20 0.36
ADRA1A P35348 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15323760 0.85 KDM4E (0.54) KDM4EALDH1A1HSD17B10GAAMAPT
SCHEMBL15324928 0.81 PDGFRB (0.43) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL7398883 0.80 KDM4E (0.58) KDM4EALDH1A1HSD17B10GAAMAPT
SCHEMBL13603003 0.77 KDM4E (0.55) KDM4EALDH1A1HSD17B10GAAMAPT
SCHEMBL29054678 0.73 KDM4E (0.53) KDM4EALDH1A1HSD17B10GAAMAPT
SCHEMBL30507871 0.73 KDM4E (0.53) KDM4EALDH1A1HSD17B10GAAMAPT
SCHEMBL7402316 0.72 ALDH1A1 (0.55) KDM4EALDH1A1HSD17B10GAAMAPT
SCHEMBL14810489 0.71 HTR4 (0.58) KDM4EALDH1A1GAAABL1HTR4
SCHEMBL6848305 0.70 KDM4E (0.56) KDM4EALDH1A1HSD17B10GAAMAPT
SCHEMBL7398875 0.70 HTR4 (0.55) KDM4EALDH1A1GAAMAPTHTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2833920-A2 MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE Moderna Therapeutics, Inc. (US) 2015-02-11 EP disclosed
WO-2013153535-A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-10-17 WO disclosed
WO-2013153535-A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-10-17 WO disclosed
WO-2013151666-A2 MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE modeRNA Therapeutics (US) 2013-10-10 WO disclosed